Clearmind Medicine Receives Approval to Commence its Phase I

Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder

Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Canada , United States , Vancouver , British Columbia , Tel Aviv , Israel , Frankfurt , Brandenburg , Germany , Ramat Gan , Israeli , Canadian , Mark Weiser , Adi Zuloff Shani , Clearmind Medicine Inc , Psychiatric Division , Exchange Commission , Frankfurt Stock Exchange , Nasdaq , Ministry Of Health Israel , Canadian Securities Exchange , Yale School Of Medicine Department Psychiatry , Sheba Medical Center , Medicine Inc , Johns Hopkins University School Of Medicine , Medicine Receives Approval , Clinical Trial , Alcohol Use , Yale School , Johns Hopkins University School , Looking Statements , Private Securities Litigation Reform Act ,